Literature DB >> 10416107

[Fall in the seroprevalence of hepatitis A in French youth].

M Joussemet1, J Depaquit, E Nicand, C Mac Nab, J B Meynard, R Teyssou, G Fabre, Y Buisson.   

Abstract

OBJECTIVE: An anti-hepatitis A virus seroprevalence survey was performed in 1997 in 1052 French army recruits (mean age: 21.2 years). To describe epidemiological trends, the current pattern was compared to previous results obtained by similar methods in 1985, 1990 and 1993.
RESULTS: In 1997, overall anti-hepatitis A virus seroprevalence was 11.5%. The greatest risk factor of hepatitis A infection was related to travel in intermediate or highly endemic areas for hepatitis A virus: 46% of overseas residents (odds ratio = 10.3), 28% of recruits who had travelled in developing countries (odds ratio = 3.7) and 7.65% of French living in industrialised countries are anti-hepatitis A virus antibody positive. Moreover, seroprevalence was higher in subjects with a history of icteria (adjusted odds ratio = 3.5) and families with at least 3 children (adjusted odds ratio = 3). No association was found with drinking water, socioeconomic status such as baccalaureat degree, or parents profession. The seroepidemiological shift of hepatitis A, as assessed in three previous studies, shows a marked decrease of 20% in 12 years from 30.4% in 1985, to 21.3% in 1990, to 16.3% in 1993, and to 11.5% in 1997. The decrease in the prevalence of anti-hepatitis A virus was more marked in young adults who had never travelled in endemic countries (decrease of 20%) than those who had visited or lived in developing countries (decrease of 10%).
CONCLUSION: Although France is not highly endemic for hepatitis A thanks to improved hygiene and housing conditions over the past 20 years, a pattern of intermediate endemicity was seen in French overseas areas in which the risk of outbreaks of hepatitis A was higher. The decrease in anti-hepatitis A virus seroprevalence in French youth can be used to draft a public health policy for hepatitis A control.

Entities:  

Mesh:

Year:  1999        PMID: 10416107

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium.

Authors:  Sophie Quoilin; Veronik Hutse; Hans Vandenberghe; Françoise Claeys; Els Verhaegen; Liesbet De Cock; Frank Van Loock; Geert Top; Pierre Van Damme; Robert Vranckx; Herman Van Oyen
Journal:  Eur J Epidemiol       Date:  2007-03-14       Impact factor: 8.082

Review 2.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

3.  Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999-2003.

Authors:  Philippe Parola; Georges Soula; Pierre Gazin; Cedric Foucault; Jean Delmont; Philippe Brouqui
Journal:  Travel Med Infect Dis       Date:  2006-03       Impact factor: 6.211

4.  Enveloped virus but not bacteria block IL-13 responses in human cord blood T cells in vitro.

Authors:  A Svensson; I Nordström; A Rudin; T Bergström; K Eriksson
Journal:  Scand J Immunol       Date:  2012-04       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.